116 related articles for article (PubMed ID: 10432479)
1. Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on trial 2 in the elevated plus-maze test of anxiety.
File SE; Gonzalez LE; Gallant R
Neuropsychopharmacology; 1999 Aug; 21(2):312-20. PubMed ID: 10432479
[TBL] [Abstract][Full Text] [Related]
2. Role of the basolateral nucleus of the amygdala in the formation of a phobia.
File SE; Gonzalez LE; Gallant R
Neuropsychopharmacology; 1998 Nov; 19(5):397-405. PubMed ID: 9778661
[TBL] [Abstract][Full Text] [Related]
3. Orexin-1 receptor antagonism fails to reduce anxiety-like behaviour in either plus-maze-naïve or plus-maze-experienced mice.
Rodgers RJ; Wright FL; Snow NF; Taylor LJ
Behav Brain Res; 2013 Apr; 243():213-9. PubMed ID: 23333844
[TBL] [Abstract][Full Text] [Related]
4. Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents.
Lalonde R; Strazielle C
Fundam Clin Pharmacol; 2010 Jun; 24(3):365-76. PubMed ID: 19735300
[TBL] [Abstract][Full Text] [Related]
5. The phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation.
Pereira JK; Vieira RJ; Konishi CT; Ribeiro RA; Frussa-Filho R
Life Sci; 1999; 65(10):PL101-7. PubMed ID: 10499876
[TBL] [Abstract][Full Text] [Related]
6. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
dos Reis LM; Canto-de-Souza A
Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
[TBL] [Abstract][Full Text] [Related]
7. Mu-opioid receptor knockout mice are more sensitive to chlordiazepoxide-induced anxiolytic behavior.
Wang KC; Lee YJ; Fan LW; Yang PP; Tao PL; Ho IK; Tien LT
Brain Res Bull; 2013 Jan; 90():137-41. PubMed ID: 23142328
[TBL] [Abstract][Full Text] [Related]
8. Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats.
Bertoglio LJ; Anzini C; Lino-de-Oliveira C; Carobrez AP
Behav Brain Res; 2005 Jul; 162(1):99-107. PubMed ID: 15922070
[TBL] [Abstract][Full Text] [Related]
9. The phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze test is abolished by previous administration of chlordiazepoxide or buspirone.
Escarabajal MD; Torres C; Flaherty CF
Life Sci; 2003 Jul; 73(8):1063-74. PubMed ID: 12818358
[TBL] [Abstract][Full Text] [Related]
10. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze.
Holmes A; Rodgers RJ
Neurosci Biobehav Rev; 1999 Nov; 23(7):971-80. PubMed ID: 10580311
[TBL] [Abstract][Full Text] [Related]
11. One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of a phobic avoidance of open arms during initial exposure.
Frussa-Filho R; Ribeiro Rde A
Life Sci; 2002 Jun; 71(5):519-25. PubMed ID: 12052436
[TBL] [Abstract][Full Text] [Related]
12. Are benzodiazepines really anxiolytic? Evidence from a 3D maze spatial navigation task.
Ennaceur A; Michalikova S; van Rensburg R; Chazot PL
Behav Brain Res; 2008 Mar; 188(1):136-53. PubMed ID: 18055029
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the rat exploratory behavior in the elevated plus-maze with Markov chains.
Tejada J; Bosco GG; Morato S; Roque AC
J Neurosci Methods; 2010 Nov; 193(2):288-95. PubMed ID: 20869398
[TBL] [Abstract][Full Text] [Related]
14. Multiple hypothalamic sites control the frequency of hippocampal theta rhythm.
Woodnorth MA; Kyd RJ; Logan BJ; Long MA; McNaughton N
Hippocampus; 2003; 13(3):361-74. PubMed ID: 12722977
[TBL] [Abstract][Full Text] [Related]
15. The anterior cingulate cortex is a target structure for the anxiolytic-like effects of benzodiazepines assessed by repeated exposure to the elevated plus maze and Fos immunoreactivity.
Albrechet-Souza L; Borelli KG; Carvalho MC; Brandão ML
Neuroscience; 2009 Dec; 164(2):387-97. PubMed ID: 19699782
[TBL] [Abstract][Full Text] [Related]
16. Absence of repeated-trial tolerance to the anxiolytic-like effects of chlordiazepoxide in the rat triple test.
Wehrmeister TD; Izídio GS; Pereira E; Izídio G; Ramos A
Pharmacol Biochem Behav; 2010 Dec; 97(2):301-9. PubMed ID: 20817009
[TBL] [Abstract][Full Text] [Related]
17. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
[TBL] [Abstract][Full Text] [Related]
18. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam.
Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
Psychopharmacology (Berl); 2002 Jan; 159(2):188-95. PubMed ID: 11862348
[TBL] [Abstract][Full Text] [Related]
19. Role of learning of open arm avoidance in the phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in mice.
Calzavara MB; Patti CL; Lopez GB; Abílio VC; Silva RH; Frussa-Filho R
Life Sci; 2005 Mar; 76(19):2235-46. PubMed ID: 15733938
[TBL] [Abstract][Full Text] [Related]
20. Effects of plus-maze experience and chlordiazepoxide on anxiety-like behavior and serotonin neural activity in the dorsal raphe nucleus in rats.
Grahn RE; Kalman BA; Vlasaty JA; Perna JA; Nevins-Herbert C; Patton SM; Barison LK
Behav Pharmacol; 2019 Apr; 30(2 and 3-Spec Issue):208-219. PubMed ID: 30169377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
